Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 12

1.

EBAG9 modulates host immune defense against tumor formation and metastasis by regulating cytotoxic activity of T lymphocytes.

Miyazaki T, Ikeda K, Horie-Inoue K, Kondo T, Takahashi S, Inoue S.

Oncogenesis. 2014 Nov 3;3:e126. doi: 10.1038/oncsis.2014.40.

2.

Increased RCAS1 expression is associated with advanced histopathological stage and poor prognosis in patients with gastric adenocarcinoma.

Giaginis C, Efkarpidis T, Alexandrou P, Patsouris E, Kouraklis G, Theocharis S.

Dis Markers. 2013;35(4):213-9. doi: 10.1155/2013/527548. Epub 2013 Sep 3.

3.

Mesencephalic astrocyte-derived neurotrophic factor (MANF) secretion and cell surface binding are modulated by KDEL receptors.

Henderson MJ, Richie CT, Airavaara M, Wang Y, Harvey BK.

J Biol Chem. 2013 Feb 8;288(6):4209-25. doi: 10.1074/jbc.M112.400648. Epub 2012 Dec 19.

4.

Receptor-binding cancer antigen expressed on SiSo cells (RCAS1) expression in human benign and malignant thyroid lesions.

Giaginis C, Demetriou N, Alexandrou P, Stolakis V, Delladetsima I, Klijanienko J, Griniatsos I, Theocharis S.

Med Sci Monit. 2012 Apr;18(4):BR123-9.

5.

Peptide-displaying phage technology in glycobiology.

Fukuda MN.

Glycobiology. 2012 Mar;22(3):318-25. doi: 10.1093/glycob/cwr140. Epub 2011 Sep 19. Review.

6.

RCAS1 expression in mobile tongue squamous cell carcinoma: an immunohistochemical study.

Theocharis S, Klijanienko J, Giaginis C, Rodriguez J, Jouffroy T, Girod A, Tsourouflis G, Sastre-Garau X.

Med Sci Monit. 2011 Aug;17(8):BR228-234.

7.

Akt3 controls vascular endothelial growth factor secretion and angiogenesis in ovarian cancer cells.

Liby TA, Spyropoulos P, Buff Lindner H, Eldridge J, Beeson C, Hsu T, Muise-Helmericks RC.

Int J Cancer. 2012 Feb 1;130(3):532-43. doi: 10.1002/ijc.26010. Epub 2011 Apr 20.

8.

Tumor-associated, estrogen receptor-related antigen EBAG9: linking intracellular vesicle trafficking, immune homeostasis, and malignancy.

Kino T, Chrousos GP.

Mol Interv. 2009 Dec;9(6):294-8. doi: 10.1124/mi.9.6.4. No abstract available.

9.

The analysis of RCAS1 and DFF-45 expression in nasal polyps with respect to immune cells infiltration.

Dutsch-Wicherek M, Tomaszewska R, Strek P, Wicherek L, Skladzien J.

BMC Immunol. 2006 Mar 21;7:4.

10.

The placental RCAS1 expression during stillbirth.

Wicherek L, Klimek M, Czekierdowski A, Popiela TJ, Galazka K, Tetlak T, Gilowski A, Dutsch-Wicherek M.

Reprod Biol Endocrinol. 2005 Jun 17;3:24.

11.

Reevaluation of the 22-1-1 antibody and its putative antigen, EBAG9/RCAS1, as a tumor marker.

Reimer TA, Anagnostopoulos I, Erdmann B, Lehmann I, Stein H, Daniel P, Dörken B, Rehm A.

BMC Cancer. 2005 May 17;5:47.

12.

EBAG9 adds a new layer of control on large dense-core vesicle exocytosis via interaction with Snapin.

Rüder C, Reimer T, Delgado-Martinez I, Hermosilla R, Engelsberg A, Nehring R, Dörken B, Rehm A.

Mol Biol Cell. 2005 Mar;16(3):1245-57. Epub 2005 Jan 5.

Items per page

Supplemental Content

Write to the Help Desk